Join
Live feed
·
INSIDERFilingvia Quantisnow
Checkpoint Therapeutics Inc. logo

CEO, President and Director Oliviero James F Iii was granted 2,077,700 shares, increasing direct ownership by 107% to 4,016,980 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CKPT· Checkpoint Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CKPT (Checkpoint Therapeutics Inc.) and more on Quantisnow.

CEO, President and Director Oliviero James F Iii was granted 2,077,700 shares, increasing direct ownership by 107% to 4,016,980 units (SEC Form 4) | Quantisnow